Single oligoarray-based detection of specific M918T mutation in RET oncogene in multiple endocrine neoplasia type 2B

被引:0
作者
Pacheco-Rivera, R. A. [2 ,7 ]
Hernandez-Zamora, E. [1 ]
Gonzalez-Yebra, B. [3 ]
Beattie, K. [4 ]
Maldonado-Rodriguez, R. [5 ]
Santiago-Hernandez, J. C. [5 ]
Medrano-Ortiz de Zarate, M. E. [6 ]
Salcedo, M. [7 ]
机构
[1] Inst Nacl Rehabil, Serv Genet, Mexico City, DF, Mexico
[2] ENCB IPN, Lab Diagnost Mol, Mexico City, DF, Mexico
[3] Univ Guanajuato, Dept Biol Mol, Guanajuato, Mexico
[4] Oak Ridge Natl Lab, Div Life Sci, Oak Ridge, TN USA
[5] ENCB IPN, Lab Biotecnol & Bioinformat Mol, Mexico City, DF, Mexico
[6] Hosp Oncol, CMN SXXI IMSS, Serv Endocrinol, Mexico City, DF, Mexico
[7] IMSS, UIMEO CMN SXXI, Lab Oncol Genom, Mexico City, DF, Mexico
关键词
Oligoarray; Mutation; MEN; 2B; RET; MEDULLARY-THYROID CARCINOMA; DNA MICROARRAYS; CODON; 634; PROTOONCOGENE; DISEASE; CANCER; HYBRIDIZATION; MANAGEMENT; FAMILIES;
D O I
10.1007/s10238-010-0128-z
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The most important mutation associated with Multiple Endocrine Neoplasia type 2B (MEN 2B) is the change of thymine to cytosine in codon 918 of exon 16 in the RET oncogene (ATG -> ACG). The aim of this work was to develop a single oligoarray by using tandem hybridization to detect the T918C/RET mutation for MEN 2B patients. Two genetically non-related families were studied; each family had a member affected by MEN2B. Both patients presented the T918C/RET mutation in a heterozygous fashion. None of the relatives was positive for this mutation; thus, these cases arose de novo. The proper mutation was confirmed by with different tools, PCR-Fok I endonuclease, direct sequencing, and also using our oligoarray. In this case, it is suitable to use a DNA target smaller than 150 bases with single-or double-stranded DNA and short probes of 7-mer. It was also possible to detect the mutation by employing different sources of DNA, fresh or paraffin-embedded tissues. Therefore, the present oligoarray can identify the most common M918T mutation of RET oncogene from a variety of DNA sources with good specificity and be a good alternative in the molecular diagnosis for MEN 2B cases.
引用
收藏
页码:227 / 234
页数:8
相关论文
共 26 条
[1]  
Bednar M, 2000, Med Sci Monit, V6, P796
[2]  
BOLINO A, 1995, ONCOGENE, V10, P2415
[3]   Exploring the new world of the genome with DNA microarrays [J].
Brown, PO ;
Botstein, D .
NATURE GENETICS, 1999, 21 (Suppl 1) :33-37
[4]   DNA microarrays in drug discovery and development [J].
Debouck, C ;
Goodfellow, PN .
NATURE GENETICS, 1999, 21 (Suppl 1) :48-50
[5]   THE RET PROTOONCOGENE AND CANCER [J].
DONISKELLER, H .
JOURNAL OF INTERNAL MEDICINE, 1995, 238 (04) :319-325
[6]  
Eng C, 1997, HUM MUTAT, V9, P97, DOI 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.3.CO
[7]  
2-Q
[8]   RET oncogene mutations in medullary thyroid carcinoma in Mexican families [J].
González, B ;
Salcedo, M ;
Medrano, ME ;
Mantilla, A ;
Quiñónez, G ;
Benítez-Bribiesca, L ;
Rodríguez-Cuevas, S ;
Cabrera, L ;
de León, B ;
Altamirano, N ;
Tapia, J ;
Dawson, B .
ARCHIVES OF MEDICAL RESEARCH, 2003, 34 (01) :41-49
[9]  
Hidalgo A, 1998, J EXP CLIN CANC RES, V17, P149
[10]  
Kim IJ, 2002, CLIN CANCER RES, V8, P457